10-K Filing

BIO GREEN MED SOLUTION, INC. CIK: 1130166 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001571049-18-000206`
Period End Date	20171231
Filing Date	20180330
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	cycc-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 37 Cash Flow Statement 41 Stockholders Equity 20 Comprehensive Income 8

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.26M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.26M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.52M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.06M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.62M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$29.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$45.00K	USD	Point-in-time
Total assets	`Assets`	$26.00M	USD	Point-in-time
Total assets	`Assets`	$19.66M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.56M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.50M	USD	Point-in-time
Accrued and other current liabilities	`AccruedLiabilitiesCurrent`	$2.56M	USD	Point-in-time
Accrued and other current liabilities	`AccruedLiabilitiesCurrent`	$2.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.11M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$124.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$130.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.24M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.39M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2016 and December 31, 2017; 4,256,829 and 11,997,447 shares issued and outstanding at December 31, 2016 and December 31, 2017, respectively.	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2016 and December 31, 2017; 4,256,829 and 11,997,447 shares issued and outstanding at December 31, 2016 and December 31, 2017, respectively.	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$350.05M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$365.06M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-743.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-794.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-335.04M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-342.51M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.84M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$21.77M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$26.00M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.66M	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
Grant revenue	`RevenueFromGrants`	$843.00K	USD	Annual
Total revenues	`SalesRevenueNet`	-	USD	Annual
Total revenues	`SalesRevenueNet`	$843.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$9.48M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.24M	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$5.25M	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$5.52M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$14.99M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$9.49M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-9.49M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-14.15M	USD	Annual
Foreign exchange gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-39.00K	USD	Annual
Foreign exchange gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$273.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$118.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$37.00K	USD	Annual
Other income, net	`OtherNonoperatingIncome`	$66.00K	USD	Annual
Other income, net	`OtherNonoperatingIncome`	$949.00K	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.03M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$376.00K	USD	Annual
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.46M	USD	Annual
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-13.77M	USD	Annual
Income tax benefit	`IncomeTaxExpenseBenefit`	$-993.00K	USD	Annual
Income tax benefit	`IncomeTaxExpenseBenefit`	$-1.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.79M	USD	Annual
Dividend on convertible exchangeable preferred shares	`PreferredStockDividendsAndOtherAdjustments`	$200.00K	USD	Annual
Dividend on convertible exchangeable preferred shares	`PreferredStockDividendsAndOtherAdjustments`	$201.00K	USD	Annual
Beneficial conversion feature of Series A convertible stock	`BeneficialConversionFeatureOfConvertibleStock`	-	USD	Annual
Beneficial conversion feature of Series A convertible stock	`BeneficialConversionFeatureOfConvertibleStock`	$3.64M	USD	Annual
Conversion of Series A convertible preferred stock	`ConvertiblePreferredStockConvertedToOtherSecurities`	$3.54M	USD	Annual
Conversion of Series A convertible preferred stock	`ConvertiblePreferredStockConvertedToOtherSecurities`	-	USD	Annual
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-11.99M	USD	Annual
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-14.85M	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.50	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.95	USD	Annual
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.42M	shares	Annual
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.63M	shares	Annual

Cash Flow Statement 41 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.79M	USD	Annual
Depreciation expense	`Depreciation`	$133.00K	USD	Annual
Depreciation expense	`Depreciation`	$32.00K	USD	Annual
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$12.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$782.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$266.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.23M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-439.00K	USD	Annual
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-1.54M	USD	Annual
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$370.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-10.08M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.48M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$12.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$9.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-13.00K	USD	Annual
Proceeds from issuance of equity securities, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$14.75M	USD	Annual
Proceeds from issuance of equity securities, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$6.79M	USD	Annual
Proceeds from the exercise of stock options and warrants, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$200.00K	USD	Annual
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$200.00K	USD	Annual
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$201.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.59M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$14.75M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-444.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$135.00K	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.92M	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.39M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$20.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.91M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$16.52M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.91M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$16.52M	USD	Point-in-time
Interest	`ProceedsFromInterestReceived`	$38.00K	USD	Annual
Interest	`ProceedsFromInterestReceived`	$118.00K	USD	Annual
Taxes	`IncomeTaxesPaid`	$1.81M	USD	Annual
Taxes	`IncomeTaxesPaid`	$1.97M	USD	Annual
Accrual of preferred stock dividends	`AccrualOfPreferredStockDividends`	$50.00K	USD	Annual
Accrual of preferred stock dividends	`AccrualOfPreferredStockDividends`	$50.00K	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$18.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.27M	USD	Point-in-time
Balance	`StockholdersEquity`	$21.77M	USD	Point-in-time
Issue of common stock, preferred stock and associated warrants on underwritten offering, net of expenses	`StockIssuedDuringPeriodValueNewIssues`	$13.68M	USD	Annual
Warrant exercise	`StockIssuedDuringPeriodValueStockWarrantsExercised`	$199.00K	USD	Annual
Issue of common stock on At Market Issuance sales agreement	`StockIssuedDuringPeriodValueAtMarketIssuanceSalesAgreement`	$6.79M	USD	Annual
Issue of common stock on At Market Issuance sales agreement	`StockIssuedDuringPeriodValueAtMarketIssuanceSalesAgreement`	$1.07M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$266.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$782.00K	USD	Annual
Preferred stock dividends	`AdjustmentsToAdditionalPaidInCapitalPreferredStockConversion`	$201.00K	USD	Annual
Preferred stock dividends	`AdjustmentsToAdditionalPaidInCapitalPreferredStockConversion`	$200.00K	USD	Annual
Unrealized foreign exchange on intercompany loans	`OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax`	$14.64M	USD	Annual
Unrealized foreign exchange on intercompany loans	`OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax`	$-27.35M	USD	Annual
Translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-14.69M	USD	Annual
Translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$27.20M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-7.47M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-11.79M	USD	Annual
Balance	`StockholdersEquity`	$18.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.27M	USD	Point-in-time
Balance	`StockholdersEquity`	$21.77M	USD	Point-in-time

Comprehensive Income 8 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.79M	USD	Annual
Translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-14.69M	USD	Annual
Translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$27.20M	USD	Annual
Unrealized foreign exchange gain (loss) on intercompany loans	`OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax`	$14.64M	USD	Annual
Unrealized foreign exchange gain (loss) on intercompany loans	`OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax`	$-27.35M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-11.94M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.52M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.